| Factor Information | |
|---|---|
| Data ID | 1481 |
| Factor | prenatal diagnosis |
| Description | prostaglandin E1(PGE) |
| Biomarker | NA |
| Classification | A2 (clinical factor - diagnosis) |
| Association | |
|---|---|
| Application | diagnosis |
| Objective | infant with CHD |
| p Value | <0.001 |
| Conclusion | Patients who were born at a hospital with PGE were more likely to have had a prenatal diagnosis of congenital heart disease. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 533 |
| CHD Type | isolated CHD |
| CHD Subtype | HLHS/TGA/CoA/IAA/PA/TOF/TA/HAA/SV |
| Reference | |
|---|---|
| PMID | 26499357 |
| Year | 2016 |
| Title | Prostaglandin Availability and Association with Outcomes for Infants with Congenital Heart Disease. |
| Sample | ||
|---|---|---|
| Population | infant | |
| Source | data | |
| Region | Houston, USA | |
| Method | Student’s t test and Wilcoxon rank-sum test | |
| Race | American | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | Local PGE group(Treatment) | non-local, no PGE group(Control) |
| Number | 265 | 40 |
| Age | 0-2 days | 0-2 days |
| Gender (Male: Female) | 156:109 | 27:13 |
| Marker Level | 0.804 | 0.025 |
